GlassScriptPhysician profile
Emily Huffman Combs
NPI 1023504685
$373.61
in general payments reported to CMS, 2019-2025
11 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.44 · 2022: $75.98 · 2023: $19.25 · 2024: $25.10 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $83.20 | 2021-2025 | |
| Verona Pharma, INC. | $65.73 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $60.95 | 2025 | Yupelri |
| Novo Nordisk INC | $37.61 | 2022 | |
| Mylan Specialty L.P. | $30.64 | 2021 | |
| Baxter Healthcare | $25.10 | 2024 | Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $19.25 | 2023 | Opsumit |
| Regeneron Healthcare Solutions, INC. | $18.62 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $14.99 | 2021 | |
| Exact Sciences Corporation | $14.28 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $3.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.